U.S. Department of Health and Human Services • National Institutes of Health

Advanced Search

NIAID > Labs & Scientific Resources > Resources for Researchers > Microbiology and Infectious Diseases Resources > Phase I Clinical Trial Units for Therapeutics

Resources for Researchers

Microbiology and Infectious Diseases Resources

Phase I Clinical Trial Units for Therapeutics

Skip Website Tools

Website Tools

Skip Stay Connected

Stay Connected

Social media privacy policy and disclaimers.

Contact Info

Mary Smith
Project Manager
mary.smith@nih.gov

Additional Information From NIAID

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on. Read more information on enabling JavaScript.

Microbiology and Infectious Diseases Resources

Skip Content Marketing

Share this:

Phase I Clinical Trial Units for Therapeutics

Eligibility Criteria

Concept proposals for clinical trials to test promising therapeutics at one or more investigational sites may be proposed by investigational site Principal Investigators (PIs), Division of Microbiology and Infectious Diseases (DMID) staff, or by outside collaborators.

Last Updated November 13, 2012

U.S. Department of Health and Human Services Text